Cardiovascular magnetic resonance evaluation of aortic stenosis severity using single plane measurement of effective orifice area

<p>Abstract</p> <p>Background</p> <p>Transthoracic echocardiography (TTE) is the standard method for the evaluation of the severity of aortic stenosis (AS). Valve effective orifice area (EOA) measured by the continuity equation is one of the most frequently used stenotic indices. However, TTE measurement of aortic valve EOA is not feasible or not reliable in a significant proportion of patients. Cardiovascular magnetic resonance (CMR) has emerged as a non-invasive alternative to evaluate EOA using velocity measurements. The objectives of this study were: 1) to validate a new CMR method using jet shear layer detection (JSLD) based on acoustical source term (AST) concept to estimate the valve EOA; 2) to introduce a simplified JSLD method not requiring vorticity field derivation.</p> <p>Methods and results</p> <p>We performed an in vitro study where EOA was measured by CMR in 4 fixed stenoses (EOA = 0.48, 1.00, 1.38 and 2.11 cm²) under the same steady flow conditions (4-20 L/min). The in vivo study included eight (8) healthy subjects and 37 patients with mild to severe AS (0.72 cm²≤ EOA ≤ 1.71 cm²). All subjects underwent TTE and CMR examinations. EOA was determinated by TTE with the use of continuity equation method (TTE_CONT). For CMR estimation of EOA, we used 3 methods: 1) Continuity equation (CMR_CONT); 2) Shear layer detection (CMR_JSLD), which was computed from the velocity field of a single CMR velocity profile at the peak systolic phase; 3) Single plane velocity truncation (CMR_SPVT), which is a simplified version of CMR_JSLDmethod. There was a good agreement between the EOAs obtained in vitro by the different CMR methods and the EOA predicted from the potential flow theory. In the in vivo study, there was good correlation and concordance between the EOA measured by the TTE_CONTmethod versus those measured by each of the CMR methods: CMR_CONT(r = 0.88), CMR_JSLD(r = 0.93) and CMR_SPVT(r = 0.93). The intra- and inter- observer variability of EOA measurements was 5 ± 5% and 9 ± 5% for TTE_CONT, 2 ± 1% and 7 ± 5% for CMR_CONT, 7 ± 5% and 8 ± 7% for CMR_JSLD, 1 ± 2% and 3 ± 2% for CMR_SPVT. When repeating image acquisition, reproducibility of measurements was 10 ± 8% and 12 ± 5% for TTE_CONT, 9 ± 9% and 8 ± 8% for CMR_CONT, 6 ± 5% and 7 ± 4% for CMR_JSLDand 3 ± 2% and 2 ± 2% for CMR_SPVT.</p> <p>Conclusion</p> <p>There was an excellent agreement between the EOA estimated by the CMR_JSLDor CMR_SPVTmethods and: 1) the theoretical EOA in vitro, and 2) the TTE_CONTEOA in vivo. The CMR_SPVTmethod was superior to the TTE and other CMR methods in terms of measurement variability. The novel CMR-based methods proposed in this study may be helpful to corroborate stenosis severity in patients for whom Doppler-echocardiography exam is inconclusive.</p

The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world

Purpose: To assess the effect of clinical factors on the development and progression of atrophy and fibrosis in patients with neovascular age-related macular degeneration (nAMD) receiving long-term treatment in the real world. Methods: An ambispective 36-month multicentre study, involving 359 nAMD patients from 17 Spanish hospitals treated according to the Spanish Vitreoretinal Society guidelines, was designed. The influence of demographic and clinical factors, including the presence and location of retinal fluid, on best-corrected visual acuity (BCVA) and progression to atrophy and/or fibrosis were analysed. Results: After 36 months of follow-up and an average of 13.8 anti-VEGF intravitreal injections, the average BCVA gain was +1.5 letters, and atrophy and/or fibrosis were present in 54.8% of nAMD patients (OR = 8.54, 95% CI = 5.85-12.47, compared to baseline). Atrophy was associated with basal intraretinal fluid (IRF) (OR = 1.87, 95% CI = 1.09-3.20), whereas basal subretinal fluid (SRF) was associated with a lower rate of atrophy (OR = 0.40, 95% CI = 0.23-0.71) and its progression (OR = 0.44, 95% CI = 0.26-0.75), leading to a slow progression rate (OR = 0.34, 95% CI = 0.14-0.83). Fibrosis development and progression were related to IRF at any visit (p < 0.001). In contrast, 36-month SRF was related to a lower rate of fibrosis (OR = 0.49, 95% CI = 0.29-0.81) and its progression (OR = 0.50, 95% CI = 0.31-0.81). Conclusion: Atrophy and/or fibrosis were present in 1 of 2 nAMD patients treated for 3 years. Both, especially fibrosis, lead to vision loss. Subretinal fluid (SRF) was associated with good visual outcomes and lower rates of atrophy and fibrosis, whereas IRF yields worse visual results and a higher risk of atrophy and especially fibrosis in routine clinical practice

Isotemporal substitution of inactive time with physical activity and time in bed: cross-sectional associations with cardiometabolic health in the PREDIMEDPlus study

Background: This study explored the association between inactive time and measures of adiposity, clinical parameters, obesity, type 2 diabetes and metabolic syndrome components. It further examined the impact of reallocating inactive time to time in bed, light physical activity (LPA) or moderate-to-vigorous physical activity (MVPA) on cardio-metabolic risk factors, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. Methods: This is a cross-sectional analysis of baseline data from 2189 Caucasian men and women (age 55-75 years, BMI 27-40 Kg/m2) from the PREDIMED-Plus study (http://www.predimedplus.com/). All participants had ≥3 components of the metabolic syndrome. Inactive time, physical activity and time in bed were objectively determined using triaxial accelerometers GENEActiv during 7 days (ActivInsights Ltd., Kimbolton, United Kingdom). Multiple adjusted linear and logistic regression models were used. Isotemporal substitution regression modelling was performed to assess the relationship of replacing the amount of time spent in one activity for another, on each outcome, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. Results: Inactive time was associated with indicators of obesity and the metabolic syndrome. Reallocating 30 min per day of inactive time to 30 min per day of time in bed was associated with lower BMI, waist circumference and glycated hemoglobin (HbA1c) (all p-values < 0.05). Reallocating 30 min per day of inactive time with 30 min per day of LPA or MVPA was associated with lower BMI, waist circumference, total fat, visceral adipose tissue, HbA1c, glucose, triglycerides, and higher body muscle mass and HDL cholesterol (all p-values < 0.05). Conclusions: Inactive time was associated with a poor cardio-metabolic profile. Isotemporal substitution of inactive time with MVPA and LPA or time in bed could have beneficial impact on cardio-metabolic health

Uterine electromyography for discrimination of labor imminence in women with threatened preterm labor under tocolytic treatment

[EN] As one of the main aims of obstetrics is to be able to detect imminent delivery in patients with threatened preterm labor, the techniques currently used in clinical practice have serious limitations in this respect. The electrohysterogram (EHG) has now emerged as an alternative technique, providing relevant information about labor onset when recorded in controlled checkups without administration of tocolytic drugs. The studies published to date mainly focus on EHG-burst analysis and, to a lesser extent, on whole EHG window analysis. The study described here assessed the ability of EHG signals to discriminate imminent labor (The ability of EHG recordings to predict imminent labor (<7days) was analyzed in preterm threatened patients undergoing tocolytic therapies by means of EHG-burst and whole EHG window analysis. The non-linear features were found to have better performance than the temporal and spectral parameters in separating women who delivered in less than 7days from those who did not.Mas-Cabo, J.; Prats-Boluda, G.; Perales Marín, AJ.; Garcia-Casado, J.; Alberola Rubio, J.; Ye Lin, Y. (2019). Uterine electromyography for discrimination of labor imminence in women with threatened preterm labor under tocolytic treatment. Medical & Biological Engineering & Computing. 57:401-411. https://doi.org/10.1007/s11517-018-1888-yS40141157Aboy M, Cuesta-Frau D, Austin D, Micó-Tormos P (2007) Characterization of sample entropy in the context of biomedical signal analysis. Conf Proc IEEE Eng Med Biol Soc:5942–5945. https://doi.org/10.1109/IEMBS.2007.4353701Aboy M, Hornero R, Abásolo D, Álvarez D (2006) Interpretation of the Lempel-Ziv complexity measure in the context of biomedical signal analysis. IEEE Trans Biomed Eng 53:2282–2288. https://doi.org/10.1109/TBME.2006.883696Chkeir A, Fleury MJ, Karlsson B, Hassan M, Marque C (2013) Patterns of electrical activity synchronization in the pregnant rat uterus. Biomed 3:140–144. https://doi.org/10.1016/j.biomed.2013.04.007Crandon AJ (1979) Maternal anxiety and neonatal wellbeing. J Psychosom Res 23:113–115. https://doi.org/10.1016/0022-3999(79)90015-1Devedeux D, Marque C, Mansour S, Germain G, Duchêne J (1993) Uterine electromyography: a critical review. Am J Obstet Gynecol 169:1636–1653. https://doi.org/10.1016/0002-9378(93)90456-SFele-Žorž G, Kavšek G, Novak-Antolič Ž, Jager F (2008) A comparison of various linear and non-linear signal processing techniques to separate uterine EMG records of term and pre-term delivery groups. Med Biol Eng Comput 46:911–922. https://doi.org/10.1007/s11517-008-0350-yFergus P, Cheung P, Hussain A, al-Jumeily D, Dobbins C, Iram S (2013) Prediction of preterm deliveries from EHG signals using machine learning. PLoS One 8:e77154. https://doi.org/10.1371/journal.pone.0077154Garfield RE, Maner WL (2006) Biophysical methods of prediction and prevention of preterm labor: uterine electromyography and cervical light-induced fluorescence—new obstetrical diagnostic techniques. In: Preterm Birth pp 131–144Garfield RE, Maner WL (2007) Physiology and electrical activity of uterine contractions. Semin Cell Dev Biol 18:289–295. https://doi.org/10.1016/j.semcdb.2007.05.004Garfield RE, Maner WL, MacKay LB et al (2005) Comparing uterine electromyography activity of antepartum patients versus term labor patients. Am J Obstet Gynecol 193:23–29. https://doi.org/10.1016/j.ajog.2005.01.050Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371:75–84. https://doi.org/10.1016/S0140-6736(08)60074-4American College of Obstetricians and Gynecologists and Committee on Practice Bulletins— Obstetrics (2012) Practice bulletin no. 127. Obstet Gynecol 119(6):1308–1317.Hadar E, Biron-Shental T, Gavish O, Raban O, Yogev Y (2015) A comparison between electrical uterine monitor, tocodynamometer and intra uterine pressure catheter for uterine activity in labor. J Matern Neonatal Med 28:1367–1374. https://doi.org/10.3109/14767058.2014.954539Hans P, Dewandre P, Brichant JF, Bonhomme V (2005) Comparative effects of ketamine on Bispectral Index and spectral entropy of the electroencephalogram under sevoflurane anaesthesia. Br J Anaesth 94:336–340. https://doi.org/10.1093/bja/aei047Hassan M, Terrien J, Marque C, Karlsson B (2011) Comparison between approximate entropy, correntropy and time reversibility: application to uterine electromyogram signals. Med Eng Phys 33:980–986. https://doi.org/10.1016/j.medengphy.2011.03.010Hassan M, Terrien J, Muszynski C et al (2013) Better pregnancy monitoring using nonlinear correlation analysis of external uterine electromyography. IEEE Trans Biomed Eng 60:1160–1166. https://doi.org/10.1109/TBME.2012.2229279Horoba K, Jezewski J, Matonia A, Wrobel J, Czabanski R, Jezewski M (2016) Early predicting a risk of preterm labour by analysis of antepartum electrohysterograhic signals. Biocybern Biomed Eng 36:574–583. https://doi.org/10.1016/j.bbe.2016.06.004Lawn JE, Wilczynska-Ketende K, Cousens SN (2006) Estimating the causes of 4 million neonatal deaths in the year 2000. Int J Epidemiol 35:706–718. https://doi.org/10.1093/ije/dyl043Lemancewicz A, Borowska M, Kuć P, Jasińska E, Laudański P, Laudański T, Oczeretko E (2016) Early diagnosis of threatened premature labor by electrohysterographic recordings—the use of digital signal processing. Biocybern Biomed Eng 36:302–307. https://doi.org/10.1016/j.bbe.2015.11.005M L WLM, LR C (2012) Noninvasive uterine electromyography for prediction of preterm delivery. Am J Obstet Gynecol 204:1–20. https://doi.org/10.1016/j.ajog.2010.09.024.NoninvasiveManer WL, Garfield RE (2007) Identification of human term and preterm labor using artificial neural networks on uterine electromyography data. Ann Biomed Eng 35:465–473. https://doi.org/10.1007/s10439-006-9248-8Maner WL, Garfield RE, Maul H, Olson G, Saade G (2003) Predicting term and preterm delivery with transabdominal uterine electromyography. Obstet Gynecol 101:1254–1260. https://doi.org/10.1016/S0029-7844(03)00341-7Marque C, Gondry J (1999) Use of the electrohysterogram signal for characterization of contractions during pregnancy. IEEE Trans Biomed Eng 46:1222–1229Maul H, Maner WL, Olson G, Saade GR, Garfield RE (2004) Non-invasive transabdominal uterine electromyography correlates with the strength of intrauterine pressure and is predictive of labor and delivery. J Matern Fetal Neonatal Med 15:297–301Mischi M, Chen C, Ignatenko T, de Lau H, Ding B, Oei SGG, Rabotti C (2018) Dedicated entropy measures for early assessment of pregnancy progression from single-channel electrohysterography. IEEE Trans Biomed Eng 65:875–884. https://doi.org/10.1109/TBME.2017.2723933Most O, Langer O, Kerner R, Ben David G, Calderon I (2008) Can myometrial electrical activity identify patients in preterm labor? Am J Obstet Gynecol 199:378. https://doi.org/10.1016/j.ajog.2008.08.003Petrou S (2005) The economic consequences of preterm birth during the first 10 years of life. BJOG 112:10–15. https://doi.org/10.1111/j.1471-0528.2005.00577.xRabotti C, Sammali F, Kuijsters N, et al (2015) Analysis of uterine activity in nonpregnant women by electrohysterography: a feasibility study. In: Proc Annu Int Conf IEEE Eng Med Biol Soc EMBS pp 5916–5919Schlembach D, Maner WL, Garfield RE, Maul H (2009) Monitoring the progress of pregnancy and labor using electromyography. Eur J Obstet Gynecol Reprod Biol 144:2–8. https://doi.org/10.1016/j.ejogrb.2009.02.016Sikora J, Matonia A, Czabański R et al (2011) Recognition of premature threatening labour symptoms from bioelectrical uterine activity signals. Arch Perinat Med 17:97–103Vinken MPGC, Rabotti C, Mischi M, van Laar JOEH, Oei SG (2010) Nifedipine-induced changes in the electrohysterogram of preterm contractions: feasibility in clinical practice. Obstet Gynecol Int 2010:325635. https://doi.org/10.1155/2010/325635Vrhovec J, Lebar AM (2012) An uterine electromyographic activity as a measure of labor progression. Appl EMG Clin Sport Med 243–268. doi: https://doi.org/10.5772/25526Vrhovec J, Macek-Lebar A, Rudel D (2007) Evaluating uterine electrohysterogram with entropy. 11th Mediterr Conf Med Biomed Eng Comput 144–147. https://doi.org/10.1007/978-3-540-73044-6_36Ye-Lin Y, Bueno-Barrachina JM, Prats-boluda G, Rodriguez de Sanabria R, Garcia-Casado J (2017) Wireless sensor node for non-invasive high precision electrocardiographic signal acquisition based on a multi-ring electrode. Measurement 97:195–202. https://doi.org/10.1016/J.MEASUREMENT.2016.11.009Ye-Lin Y, Garcia-Casado J, Prats-Boluda G, Alberola-Rubio J, Perales A (2014) Automatic identification of motion artifacts in EHG recording for robust analysis of uterine contractions. Comput Math Methods Med 2014:1–11. https://doi.org/10.1155/2014/470786Zhang XS, Roy RJ, Jensen EW (2001) EEG complexity as a measure of depth of anesthesia for patients. IEEE Trans Biomed Eng 48:1424–1433. https://doi.org/10.1109/10.96660

Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis

BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London

Positive Selection Results in Frequent Reversible Amino Acid Replacements in the G Protein Gene of Human Respiratory Syncytial Virus

Human respiratory syncytial virus (HRSV) is the major cause of lower respiratory tract infections in children under 5 years of age and the elderly, causing annual disease outbreaks during the fall and winter. Multiple lineages of the HRSVA and HRSVB serotypes co-circulate within a single outbreak and display a strongly temporal pattern of genetic variation, with a replacement of dominant genotypes occurring during consecutive years. In the present study we utilized phylogenetic methods to detect and map sites subject to adaptive evolution in the G protein of HRSVA and HRSVB. A total of 29 and 23 amino acid sites were found to be putatively positively selected in HRSVA and HRSVB, respectively. Several of these sites defined genotypes and lineages within genotypes in both groups, and correlated well with epitopes previously described in group A. Remarkably, 18 of these positively selected tended to revert in time to a previous codon state, producing a “flip-flop” phylogenetic pattern. Such frequent evolutionary reversals in HRSV are indicative of a combination of frequent positive selection, reflecting the changing immune status of the human population, and a limited repertoire of functionally viable amino acids at specific amino acid sites

Long daytime napping is associated with increased adiposity and type 2 diabetes in an elderly population with metabolic syndrome

Research examining associations between objectively-measured napping time and type 2 diabetes (T2D) is lacking. This study aimed to evaluate daytime napping in relation to T2D and adiposity measures in elderly individuals from the Mediterranean region. A cross-sectional analysis of baseline data from 2190 elderly participants with overweight/obesity and metabolic syndrome, in the PREDIMED-Plus trial, was carried out. Accelerometer-derived napping was measured. Prevalence ratios (PR) and 95% confidence intervals (CI) for T2D were obtained using multivariable-adjusted Cox regression with constant time. Linear regression models were fitted to examine associations of napping with body mass index (BMI) and waist circumference (WC). Participants napping ≥90 min had a higher prevalence of T2D (PR 1.37 (1.06, 1.78)) compared with those napping 5 to <30 min per day. Significant positive associations with BMI and WC were found in those participants napping ≥30 min as compared to those napping 5 to <30 min per day. The findings of this study suggest that longer daytime napping is associated with higher T2D prevalence and greater adiposity measures in an elderly Spanish population at high cardiovascular risk

Genome-wide significant association with seven novel multiple sclerosis risk loci

Objective: A recent large-scale study in multiple sclerosis (MS) using the ImmunoChip platform reported on 11 loci that showed suggestive genetic association with MS. Additional data in sufficiently sized and independent data sets are needed to assess whether these loci represent genuine MS risk factors. Methods: The lead SNPs of all 11 loci were genotyped in 10 796 MS cases and 10 793 controls from Germany, Spain, France, the Netherlands, Austria and Russia, that were independent from the previously reported cohorts. Association analyses were performed using logistic regression based on an additive model. Summary effect size estimates were calculated using fixed-effect meta-analysis. Results: Seven of the 11 tested SNPs showed significant association with MS susceptibility in the 21 589 individuals analysed here. Meta-analysis across our and previously published MS case-control data (total sample size n=101 683) revealed novel genome-wide significant association with MS susceptibility (p<5×10−8) for all seven variants. This included SNPs in or near LOC100506457 (rs1534422, p=4.03×10−12), CD28 (rs6435203, p=1.35×10−9), LPP (rs4686953, p=3.35×10−8), ETS1 (rs3809006, p=7.74×10−9), DLEU1 (rs806349, p=8.14×10−12), LPIN3 (rs6072343, p=7.16×10−12) and IFNGR2 (rs9808753, p=4.40×10−10). Cis expression quantitative locus effects were observed in silico for rs6435203 on CD28 and for rs9808753 on several immunologically relevant genes in the IFNGR2 locus. Conclusions: This study adds seven loci to the list of genuine MS genetic risk factors and further extends the list of established loci shared across autoimmune diseases

Genome-wide significant association with seven novel multiple sclerosis risk loci

Objective: A recent large-scale study in multiple sclerosis (MS) using the ImmunoChip platform reported on 11 loci that showed suggestive genetic association with MS. Additional data in sufficiently sized and independent data sets are needed to assess whether these loci represent genuine MS risk factors. Methods: The lead SNPs of all 11 loci were genotyped in 10 796 MS cases and 10 793 controls from Germany, Spain, France, the Netherlands, Austria and Russia, that were independent from the previously reported cohorts. Association analyses were performed using logistic regression based on an additive model. Summary effect size estimates were calculated using fixed-effect meta-analysis. Results: Seven of the 11 tested SNPs showed significant association with MS susceptibility in the 21 589 individuals analysed here. Meta-analysis across our and previously published MS case-control data (total sample size n=101 683) revealed novel genome-wide significant association with MS susceptibility (p<5×10−8) for all seven variants. This included SNPs in or near LOC100506457 (rs1534422, p=4.03×10−12), CD28 (rs6435203, p=1.35×10−9), LPP (rs4686953, p=3.35×10−8), ETS1 (rs3809006, p=7.74×10−9), DLEU1 (rs806349, p=8.14×10−12), LPIN3 (rs6072343, p=7.16×10−12) and IFNGR2 (rs9808753, p=4.40×10−10). Cis expression quantitative locus effects were observed in silico for rs6435203 on CD28 and for rs9808753 on several immunologically relevant genes in the IFNGR2 locus. Conclusions: This study adds seven loci to the list of genuine MS genetic risk factors and further extends the list of established loci shared across autoimmune diseases

Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

Amyloid-beta 42 (A beta 42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF) reflect core features of the pathogenesis of Alzheimer's disease (AD) more directly than clinical diagnosis. Initiated by the European Alzheimer & Dementia Biobank (EADB), the largest collaborative effort on genetics underlying CSF biomarkers was established, including 31 cohorts with a total of 13,116 individuals (discovery n = 8074; replication n = 5042 individuals). Besides the APOE locus, novel associations with two other well-established AD risk loci were observed; CR1 was shown a locus for A beta 42 and BIN1 for pTau. GMNC and C16orf95 were further identified as loci for pTau, of which the latter is novel. Clustering methods exploring the influence of all known AD risk loci on the CSF protein levels, revealed 4 biological categories suggesting multiple A beta 42 and pTau related biological pathways involved in the etiology of AD. In functional follow-up analyses, GMNC and C16orf95 both associated with lateral ventricular volume, implying an overlap in genetic etiology for tau levels and brain ventricular volume.Peer reviewe